Who Owns KAPA?

Kairos Pharma, Ltd. — Institutional Ownership & 13F Holdings

$0.57

-0.01 (-2.54%)

Market Cap

$12.8M

Shares Outstanding

21,411,198

Institutional Holders

8

Total Inst. Value

$1.5M

% of Float Held

18.1%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$1.3M1,404,000
2Scientech Research LLC$45K48,198
3Aptus Capital Advisors, LLC$41K44,286
4SevenBridge Financial Group, LLC$28K44,286
5GEODE CAPITAL MANAGEMENT, LLC$19K20,433
6CITADEL ADVISORS LLC$12K13,230
7UBS Group AG$3K2,792
8BANK OF AMERICA CORP /DE/$021

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
CITADEL ADVISORS LLC+2K$12K
BANK OF AMERICA CORP /DE/+8$0

Top Sellers

FundShares RemovedValue
UBS Group AG-8K$3K

Related Stocks

Frequently Asked Questions

How many institutional investors hold KAPA?

As of Q1 2025, 8 institutional investors report holding KAPA (Kairos Pharma, Ltd.) in their 13F filings.

What percentage of Kairos Pharma, Ltd. is owned by institutions?

Institutional investors hold approximately 18.1% of Kairos Pharma, Ltd.'s float as reported in SEC 13F filings.

Which hedge fund owns the most KAPA?

The largest institutional holder of KAPA is ARMISTICE CAPITAL, LLC with $1.3M in shares.

Are institutions buying or selling KAPA?

This quarter, 5 institutions opened new positions in KAPA and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.